Jake Galson

Head of Technology @alchemabtx

[Lavita.AI @LavitaAI]

In the next session of Lavita AI's "Health Innovators" webcast, we will sit down with Dr. Jake Galson @jakegalson, VP of Technology at Alchemab Therapeutics, a leading startup at the intersection of biotech and AI. In this cast (Dec 23rd, 2025, noon Pacific Time) we will hear from Dr. Galson's work at the forefront of antibody-based drug discovery + AI, and discuss opportunities ahead for personalized and AI-driven biotech. We hope to see you there!

[Jake Galson @jakegalson]

Looking forward to talking more about the Alchemab platform at #AIRRC6

[Jinwoo Leem @ideasbyjin]

Really excited to announce that AntiBERTa is now published in @Patterns_CP! Here we describe a transformer model that demonstrates understanding of antibody sequences 🧵 (1/6)

#machinelearning #antibodies #drugdiscovery
https://t.co/lzeqiueNSh

[Jinwoo Leem @ideasbyjin]

The @alchemabtx team are excited by the huge growth of BCR repertoire sequencing and analysis! We collected a list of papers in this space – feel free to share and contribute👍 #BCRs #antibodies #papers #datasets #machinelearning

https://t.co/rqmLeFEOjz

[Jake Galson @jakegalson]

@AlexYermanos @victorgreiff Really nice work

[Jinwoo Leem @ideasbyjin]

@alchemabtx's tech team are delighted to present our latest pre-print on an antibody-specific language model, AntiBERTa, on bioRxiv! #antibodies #transformers #biotech (1/5)

https://t.co/4Fz3bCS4fu

[Jinwoo Leem @ideasbyjin]

We're excited to announce the release of Parapred-PyTorch! It is a deep learning tool that allows researchers to rapidly predict the probability that a specific CDR position is part of the antibody binding site.
https://t.co/fctSTgbYUE
(1/n)

[Jake Galson @jakegalson]

We're #hiring again! A great opportunity to work within a talented team on some unique antibody datasets.

We also have some fantastic Scientist/Senior Scientist openings as well - https://t.co/nm691jixGM https://t.co/Ovuw59rf6l

[Eve Richardson @EveRichardson20]

The work that we presented at MABRA in january is online now. Many thanks to my co-authors and to @KymabLtd!

[Konrad Krawczyk @antibodymap]

Review of Deep Learning methods for antibodies: https://t.co/Gu8P2AUKGk

[Jake Galson @jakegalson]

Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures https://t.co/0u3buSuY1G

[Oxford Protein Informatics Group (OPIG) @OPIGlets]

Check out our new preprint, that uses structural analysis to show that the public antibody repertoire may be much larger than previously thought! https://t.co/cmBZ4x3rMW

#antibodies #immunology

[Jake Galson @jakegalson]

We're #hiring a Bioinformatician and Bioinformatics Developer at Alchemab Therapeutics Ltd… #bioinformatics https://t.co/VN9Pl4WLkz

[nf-core @nf_core]

Pipeline release! nf-core/bcellmagic v1.1.0 (B cell repertoire analysis pipeline with immcantation framework.)

See the changelog: https://t.co/sK9vnwQTOW

[B-T.CR @bcr_tcr]

Bioinformatician & Front-End Developer, Kymab Ltd, Cambridge, UK https://t.co/fgyFOFHG2o

[Medical Sciences @OxfordMedSci]

Collaborate with Cerevance, @KymabLtd, @Immunocore, @novonordisk as part of our fully funded iCASE #PhD studentship. Find out more about the available projects and apply https://t.co/LHuXr3LeOj

[Kymab Ltd @KymabLtd]

Excited to be presenting Kymab’s IntelliSelect poster at #AIRR2017